Societal CDMO (formerly Recro) Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Societal CDMO (formerly Recro)'s estimated annual revenue is currently $56.3M per year.(i)
  • Societal CDMO (formerly Recro)'s estimated revenue per employee is $201,000

Employee Data

  • Societal CDMO (formerly Recro) has 280 Employees.(i)
  • Societal CDMO (formerly Recro) grew their employee count by -5% last year.

Societal CDMO (formerly Recro)'s People

NameTitleEmail/Phone
1
VP - InnovationReveal Email/Phone
2
VP FinanceReveal Email/Phone
3
VP Business DevelopmentReveal Email/Phone
4
VP Operations & Site HeadReveal Email/Phone
5
VP, Regulatory Affairs and PharmacovigilanceReveal Email/Phone
6
VP Tech Ops and Site HeadReveal Email/Phone
7
VP SalesReveal Email/Phone
8
VP People, Culture and ESGReveal Email/Phone
9
VP QualityReveal Email/Phone
10
VP, SalesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Societal CDMO (formerly Recro)?

Societal CDMO is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services the global pharmaceutical market. In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, totaling 145,000 square feet, in Gainesville, Georgia, and San Diego, California.

keywords:N/A

N/A

Total Funding

280

Number of Employees

$56.3M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$63.1M280215%N/A
#2
$78.5M28119%N/A
#3
$76.3M2829%N/A
#4
$76M2828%N/A
#5
$83.8M2827%N/A